Literature DB >> 26482968

Reversed-polarity T(reg) cell TCRs provide a shock.

Mark Peakman1, Andrew K Sewell2.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26482968     DOI: 10.1038/ni.3289

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


× No keyword cloud information.
  13 in total

1.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

Authors:  Sefina Arif; Timothy I Tree; Thomas P Astill; Jennifer M Tremble; Amanda J Bishop; Colin M Dayan; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

2.  Reconciling views on T cell receptor germline bias for MHC.

Authors:  K Christopher Garcia
Journal:  Trends Immunol       Date:  2012-07-06       Impact factor: 16.687

Review 3.  T cell receptor bias for MHC: co-evolution or co-receptors?

Authors:  Sneha Rangarajan; Roy A Mariuzza
Journal:  Cell Mol Life Sci       Date:  2014-03-17       Impact factor: 9.261

4.  T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex.

Authors:  Dennis X Beringer; Fleur S Kleijwegt; Florian Wiede; Arno R van der Slik; Khai Lee Loh; Jan Petersen; Nadine L Dudek; Gaby Duinkerken; Sandra Laban; Antoinette Joosten; Julian P Vivian; Zhenjun Chen; Adam P Uldrich; Dale I Godfrey; James McCluskey; David A Price; Kristen J Radford; Anthony W Purcell; Tatjana Nikolic; Hugh H Reid; Tony Tiganis; Bart O Roep; Jamie Rossjohn
Journal:  Nat Immunol       Date:  2015-10-05       Impact factor: 25.606

5.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

6.  Proinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.

Authors:  S L Thrower; L James; W Hall; K M Green; S Arif; J S Allen; C Van-Krinks; B Lozanoska-Ochser; L Marquesini; S Brown; F S Wong; C M Dayan; M Peakman
Journal:  Clin Exp Immunol       Date:  2008-11-20       Impact factor: 4.330

Review 7.  The T cell antigen receptor: the Swiss army knife of the immune system.

Authors:  M Attaf; M Legut; D K Cole; A K Sewell
Journal:  Clin Exp Immunol       Date:  2015-05-14       Impact factor: 4.330

8.  Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.

Authors:  Bronwen R Burton; Graham J Britton; Hai Fang; Johan Verhagen; Ben Smithers; Catherine A Sabatos-Peyton; Laura J Carney; Julian Gough; Stephan Strobel; David C Wraith
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

9.  Human TCR-binding affinity is governed by MHC class restriction.

Authors:  David K Cole; Nicholas J Pumphrey; Jonathan M Boulter; Malkit Sami; John I Bell; Emma Gostick; David A Price; George F Gao; Andrew K Sewell; Bent K Jakobsen
Journal:  J Immunol       Date:  2007-05-01       Impact factor: 5.422

10.  Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes.

Authors:  Sefina Arif; Pia Leete; Vy Nguyen; Katherine Marks; Nurhanani Mohamed Nor; Megan Estorninho; Deborah Kronenberg-Versteeg; Polly J Bingley; John A Todd; Catherine Guy; David B Dunger; Jake Powrie; Abby Willcox; Alan K Foulis; Sarah J Richardson; Emanuele de Rinaldis; Noel G Morgan; Anna Lorenc; Mark Peakman
Journal:  Diabetes       Date:  2014-06-17       Impact factor: 9.461

View more
  1 in total

Review 1.  Interplay of Regulatory T Cell and Th17 Cells during Infectious Diseases in Humans and Animals.

Authors:  Sharvan Sehrawat; Barry T Rouse
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.